NEUARTIGE HETERODIMERE PROTEINE
European patent · EP2943511 · In force
Register entry
- Publication number
- EP2943511
- Application number
- EP14738267
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 14, 2014
- Published
- Nov 18, 2015
- Granted
- Aug 7, 2019
- Protection ends at the latest
- Jan 13, 2034
- Next annual fee due
- Jan 31, 2027
- IPC classes
- C07K 16/46 (2006.01)
- Priority
- US 201361752348 P 14.01.2013US 201361764954 P 14.02.2013US 201361778157 P 12.03.2013US 201361780334 P 13.03.2013US 201361818153 P 01.05.2013US 201361818410 P 01.05.2013US 201361913832 P 09.12.2013US 201361913870 P 09.12.2013
- PCT application
- PCT/US2014/011549 14.01.2014
- PCT publication
- WO2014/110601 17.07.2014
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
- Feb 1, 2023
Change
Published in Swissreg on 01.02.2023
- May 16, 2022
Address changed
- Representative
- RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich
Published in Swissreg on 16.05.2022
- Sep 21, 2019
Agent entered
- Representative
- RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich
Published in Swissreg on 21.09.2019
- Aug 7, 2019
Granted
Published in Swissreg on 07.08.2019
Parties
Inventor
BERNETT, Matthew J.
Monrovia, CA 91016, US
MOORE, Gregory
Monrovia, CA 91016, US
DESJARLAIS, John
Monrovia, CA 91016, US
RASHID, Rumana
Monrovia, CA 91016, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.